FDG PET For Myocardial Viability Gains Positive Coverage Decision From CMS
This article was originally published in The Gray Sheet
Executive Summary
FDG positron emission tomography's high specificity in determining myocardial viability following revascularization establishes the technology's value as a stand-alone diagnostic, according to a Feb. 20 1national coverage decision issued by CMS